Literature DB >> 5054722

Plasma lipoproteins, glucose tolerance and insulin response in primary gout.

E Wiedemann, H G Rose, E Schwartz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5054722     DOI: 10.1016/0002-9343(72)90172-6

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  8 in total

1.  [Uric acid concentration in serum in different types of hyperlipoproteinemia, myocardial infarction and primary gout].

Authors:  U H Klemens; P von Löwis of Menar
Journal:  Klin Wochenschr       Date:  1975-04-15

2.  Hyperlipidaemia in hyperuricaemia and gout.

Authors:  B Emmerson
Journal:  Ann Rheum Dis       Date:  1998-09       Impact factor: 19.103

3.  Gout and hyperlipidaemia.

Authors:  T Gibson; R Grahame
Journal:  Ann Rheum Dis       Date:  1974-07       Impact factor: 19.103

4.  Abnormal regulation of carbohydrate metabolism in primary gout.

Authors:  H S Diamond; A C Carter; E B Feldman
Journal:  Ann Rheum Dis       Date:  1974-11       Impact factor: 19.103

5.  WDR1 and CLNK gene polymorphisms correlate with serum glucose and high-density lipoprotein levels in Tibetan gout patients.

Authors:  Bing Lan; Peng Chen; Mutu Jiri; Na He; Tian Feng; Kai Liu; Tianbo Jin; Longli Kang
Journal:  Rheumatol Int       Date:  2015-10-05       Impact factor: 2.631

6.  Diffuse idiopathic skeletal hyperostosis and new bone formation in male gouty subjects. A radiologic study.

Authors:  G O Littlejohn; S Hall
Journal:  Rheumatol Int       Date:  1982       Impact factor: 2.631

7.  Serum lipids and lipoproteins in patients with primary gout.

Authors:  A Ulreich; G M Kostner; K P Pfeiffer; P Sedlmayr; F Rainer
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

8.  Hyperlipoproteinaemia in primary gout: hyperlipoproteinaemic phenotype and influence of alcohol intake and obesity in Japan.

Authors:  S Jiao; K Kameda; Y Matsuzawa; S Tarui
Journal:  Ann Rheum Dis       Date:  1986-04       Impact factor: 19.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.